Dr. Acharya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1411 N Beckley Ave
Pavilion 111 Ste 464
Dallas, TX 75203Phone+1 214-948-3101Fax+1 214-941-7633
Summary
- I am a board-certified urologist practicing in Dallas and Dallas area. I am a general urologist but have interest in robotic urology for cancerous and non-cancerous conditions in men and women. I am the section chief of Urology at Methodist Dallas Medical Center. I serve as the Surgery Chair for US Oncology.
My educational background includes my bachelor's degree from The Johns Hopkins University (Biology with Minors in Philosophy and Economics), medical degree from The Baylor College of Medicine, Urology Residency from The University of Chicago Medical Center, and fellowship in Minimally Invasive, Robotic and Endourology from The Loyola University Medical Center.
Education & Training
University of ChicagoResidency, Urology, 2004 - 2010
Baylor College of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2011 - 2026
IL State Medical License 2008 - 2011- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013
Publications & Presentations
PubMed
- 50 citationsPaediatric robotic‐assisted laparoscopic augmentation ileocystoplasty and Mitrofanoff appendicovesicostomy (RALIMA): feasibility of and initial experience with the Uni...Mohan S. Gundeti, Sujeet S. Acharya, Gregory P. Zagaja, Arieh L. Shalhav
BJU International. 2011-03-01 - 5 citationsEvolution of open radical retropubic prostatectomy--how have open surgeons responded to the challenge of minimally invasive surgery?Sujeet S. Acharya, Kevin C. Zorn, Sergey Shikanov, Alan Thong, Gregory P. Zagaja
Journal of Endourology. 2009-11-05 - 10 citationsStress-activated kinase pathway alteration is a frequent event in bladder cancer.Kristen Otto, Sujeet S. Acharya, Victoria L. Robinson
Urologic Oncology. 2012-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
